Prostate Cancer Biomarkers
PSA (Prostate-Specific Antigen) is the primary biomarker for prostate cancer — used for screening, diagnosis, and monitoring — while newer markers like PCA3 help reduce unnecessary biopsies.
Reviewed by XpertPatient Medical Advisory · Updated June 2026 · Sources: NCI · ACS · ASCO · NIH/PMC
Start Here
What is a biomarker?
A biomarker is a measurable signal in your blood or tissue. In prostate cancer, the most important biomarker is PSA — a protein your prostate makes. When prostate cancer is present, PSA levels often rise.
The most important question in prostate cancer is usually not just ‘do I have cancer?’ — it’s ‘how aggressive is it?’ Biomarker tests help your doctor answer that. Some prostate cancers grow slowly and can be watched. Others need treatment right away. Biomarkers help sort this out.
What this means for you: Your doctor uses PSA and other markers together to decide: does this cancer need treatment now, or is careful monitoring the right approach?
The Tests Your Doctor Orders
🔍 Is a prostate-produced protein elevated in your blood?
PSA is the most widely used prostate cancer blood test. A rising PSA over time is often more meaningful than one high reading. It’s used for screening, diagnosis, and checking if treatment is working.
🔍 Does a urine test show signs of cancer activity?
PCA3 is measured from urine after a prostate exam. A high score suggests cancer is more likely. This can help your doctor decide whether a biopsy is really needed — potentially saving you from an unnecessary procedure.
🔍 Did two genes accidentally join in your cancer cells?
This gene fusion is found in about half of all prostate cancers. It helps doctors understand the biology of your cancer and is being studied as a future treatment target.
🔍 Does your cancer need male hormones to grow?
Most prostate cancers depend on testosterone to grow. If AR-positive, hormone-blocking therapy can slow or stop that growth. When the cancer stops responding to hormone therapy, it’s called castration-resistant prostate cancer.
Sources: Mayo Clinic · NIH/PMC · PCF
Watch & Learn
Common Questions
Prostate Cancer Biomarkers — Your Questions Answered
What PSA level should I be worried about?
There is no single danger number. PSA above 4.0 ng/mL often prompts more testing, but a PSA that keeps rising over time matters more than any single reading. Your doctor considers your age and prostate size too.
Can I skip a biopsy if my PSA is high?
Sometimes. Tests like PCA3 give your doctor more information before deciding. If these suggest low risk, monitoring may be a better choice than an immediate biopsy.
What does hormone therapy do for prostate cancer?
It lowers testosterone in your body or blocks your cancer from using it. Since most prostate cancers need testosterone to grow, this can slow or stop the cancer for years.
What is active surveillance?
Active surveillance means closely monitoring low-risk prostate cancer with regular PSA tests, exams, and biopsies — without immediate treatment. It’s appropriate for many men with slow-growing, low-risk cancer.
Know Your Biomarkers. Own Your Journey.
Free, survivor-led cancer education for newly diagnosed patients.
Visit the Prostate Cancer Center → Full Biomarkers Guide →
